Genor Biopharma and Abogen Biosciences Announce a Cooperative Development Agreement to Jointly Develop Globally Innovative mRNA Products and Related Pharmaceuticals

Genor Biopharma obtains IND approval from NMPA to commence the phase I/II clinical trial of GB263T, the world's first EGFR/cMET/cMET tri-specific antibody

Genor Biopharma obtains IND approval to commence the phase I/II clinical trial of GB261